Currently out of the existing stock ratings of Craig Bijou, 50 are a BUY (62.5%), 21 are a HOLD (26.25%), 9 are a SELL (11.25%).

Craig Bijou

Work Performance Price Targets & Ratings Chart

Analyst Craig Bijou, currently employed at BAML, carries an average stock price target met ratio of 74.31% that have a potential upside of 24.98% achieved within 304 days.

Craig Bijou’s has documented 173 price targets and ratings displayed on 25 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on GEHC, GE HealthCare Technologies at 05-Jan-2026.

Wall Street Analyst Craig Bijou

Analyst best performing recommendations are on RMED (RA MEDICAL SYSTEMS).
The best stock recommendation documented was for RMED (RA MEDICAL SYSTEMS) at 8/13/2019. The price target of $2500 was fulfilled within 7 days with a profit of $987.5 (65.29%) receiving and performance score of 93.27.

Average potential price target upside

of $31.91 (30.41%) on ZBH (ZIMMER BIOMET HOLDINGS).
of $27.9 (15.94%) on ISRG (INTUITIVE SURGICAL).
of $21.92 (12.26%) on SYK (STRYKER).

ISRG Intuitive Surgical OFIX Orthofix Medical AXGN Axogen GMED Globus Medical IART Integra LifeSciences Holdings SIBN Si-Bone VRAY ViewRay NUVA NuVasive RMED RA Medical Systems SYK Stryker WMGI Wright Medical Group N.V ITGR Integer Holdings Corp BLCO Bausch + Lomb Corp PRCT Procept Biorobotics Corp RXST Rxsight COO The Cooper Companies Common Stock MMSI Merit Medical Systems GEHC GE HealthCare Technologies BWAY Brainsway Ltd CERS Cerus SPNE SeaSpine Holdings Corp TFX Teleflex XGN Exagen ZBH Zimmer Biomet Holdings HAE Haemonetics

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Matt Miksic (BARCLAYS)